Should the pharmaceutical maker has lots of suppliers, then these suppliers should also be assessed by classifying them into diverse concentrations centered on their impact on the medicinal product or service.="" in="" accordance="" with="" the="" regulatory="" overall flexibility="" act,="" fda="" has="" viewed as="" the="" result="" of="" this=""